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PURPOSE. Fuchs’ endothelial corneal dystrophy (FECD), a degenerative disease of the corneal
endothelium that leads to vision loss, is a leading cause of corneal transplantation. The cause
of this disease is still unknown, but the implication of oxidative stress is strongly suggested. In
this study, we analyzed the impact of FECD on mitochondrial DNA (mtDNA) integrity and
telomere length, both of which are affected by the oxidative status of the cell.
METHODS. We compared the levels of total mtDNA, mtDNA common deletion (4977 bp), and
relative telomere length in the corneal endothelial cells of fresh Descemet’s membrane-
endothelium explants and cultured cells from healthy and late stage FECD subjects. Oxidant-
antioxidant gene expression and sensitivity to ultraviolet A (UVA)- and H2O2-induced cell
death were assessed in cultured cells.
RESULTS. Our results revealed increased mtDNA levels and telomere shortening in FECD
explants. We also found that cell culture restores a normal phenotype in terms of mtDNA
levels, telomere length, oxidant-antioxidant gene expression balance, and sensitivity to
oxidative stress-induced cell death in the FECD cells compared with the healthy cells.
CONCLUSIONS. Taken together, these results bring new evidence of the implication of oxidative
stress in FECD. They also show that FECD does not evenly affect the integrity of corneal
endothelial cells and that cell culture can rehabilitate the molecular phenotypes related to
oxidative stress by selecting the more functional FECD cells.
Keywords: corneal endothelial cells, Fuchs’ endothelial corneal dystrophy, mitochondria,
oxidation, telomere
The posterior layer of the human cornea, the cornealendothelium, is crucial for corneal transparency, because
it controls corneal deturgescence. Fuchs’ endothelial corneal
dystrophy (FECD) is a degenerative disease of the corneal
endothelium. The prevalence of FECD in the United States is
estimated at 897 per million individuals, and the symptoms
usually appear after 60 years of age.1 FECD is typically
characterized by an abnormal deposition of extracellular matrix
on the posterior aspect of Descemet’s membrane, generating
excrescences called guttae. The progressive enlargement of
these guttae is associated with a progressive and irreversible
loss of endothelial cells. This leads to corneal edema, which, if
left untreated, results in painful bullous keratopathy, scarring,
and blindness.2,3 The only treatment currently available to
restore sight is corneal endothelial transplantation.2 FECD is the
leading indication for corneal endothelial transplantation and
was responsible for 53.4% of the 28,064 endothelial kerato-
plasties performed in the United States in 2014. The cause of
the disease is believed to involve hereditary and hormonal and
environmental factors.4
The corneal endothelium is continuously exposed to
endogenous and exogenous oxidative stress. Its deturgescence
activity induces a high aerobic metabolism. To compensate for
the leakage of fluid from the aqueous humor to the corneal
stroma, endothelial basolateral Naþ/Kþ-ATPases and Naþ/HCO3
–
co-transporters actively transport ions, generating an osmotic
gradient and thus a water flux out of the cell to the anterior
chamber.5 This high aerobic metabolism leads to endogenous
oxidation and generation of reactive oxygen species (ROS). The
cornea is also constantly exposed to sunlight ultraviolet (UV)
radiation, the UV A portion of which reaches the corneal
endothelium.6,7 UVA light is well described as an exogenous
oxidizer that generates ROS.8 Together, the high aerobic
metabolism, the lifetime exposure to toxic sunlight, and the
fact that the corneal endothelial cells in vivo are arrested in the
G1 phase of the cycle (i.e., nonmitotic cells) make the corneal
endothelium prone to oxidative stress.9
Generation of ROS from both endogenous and exogenous
sources can oxidize DNA and induce the mutagenic 8-hydroxy-
20-deoxyguanosine (8-oxoG). Accumulation of 8-oxoG was
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recently described in FECD corneal endothelial cells, mostly at
the level of mitochondrial DNA (mtDNA).3,10 mtDNA is highly
susceptible to oxidative damage because of its direct exposure
to the ROS-generating respiratory chain and its lack of histone
protection.10,11 Damage to the mtDNA can cause loss of
integrity of the inner mitochondrial membrane potential,
apoptosis, and accumulation mtDNA deletions, leading to
dysfunctional synthesis of mitochondrial proteins.12–14 Telo-
meric DNA is also sensitive to oxidative damage, which induces
telomeric shortening, acceleration of cellular senescence, and
impaired cell function.15,16,17
Several observations indicate that FECD cells are poorly
protected against oxidative stress. (1) The DJ-1 protein, known
to protect against oxidative damage, is downregulated in FECD.
This results in an impaired nuclear factor erythroid 2-related
factor 2 (Nrf2) nuclear translocation.18 Nrf2 is a transcription
factor that regulates the expression of antioxidant proteins.
The impaired translocation of Nrf2 sensitizes the corneal
endothelial cell to UVA light by decreasing the expression of
antioxidant genes, increasing oxidative damage, and activating
p53-dependant apoptosis.9,19 (2) Transcriptome analyses have
shown that mitochondrial antioxidant genes, such as superox-
ide dismutase 2 (SOD2) and Prx3, are downregulated in
FECD.20 (3) Oxidative stress involving lipid peroxidation,
advanced glycation end-products, and other ROS was shown
to be implicated in FECD.21,22 (4) An imbalance in oxidant-
antioxidant toward a pro-oxidant state was documented in
FECD in several studies.3,10,23
Our group recently showed that FECD endothelial cells
could be successfully cultured without transduction. We also
demonstrated that the diseased endothelial cells of clinically
decompensated FECD corneas, when cultured and seeded on a
devitalized stromal carrier and transplanted into the living
animal eye, can recover active pump function and restore
corneal transparency for at least 7 days after transplantation.24
The partial recovery in culture of these end-stage FECD
endothelial cells harvested from the central and most diseased
part of the cornea has opened the door to a new perspective,
which is herein analyzed from an ‘‘oxidation standpoint.’’
The goal of this study was to investigate the effect of cell
culture on the oxidative imbalance documented in FECD
corneal endothelial cells. More specifically, using specimens
from FECD and normal subjects, we compared the corneal
endothelial cells of fresh corneal endothelial explants with
endothelial cells in culture, looking for differences in
mitochondrial DNA levels, mtDNA integrity, telomere shorten-
ing, sensitivity to oxidative stress-induced cell death, and
oxidant-antioxidant gene expression. Increased mtDNA levels
and telomere shortening were observed in fresh FECD explants
but not in cultured FECD cells. On the other hand,
mitochondrial integrity, oxidant-antioxidant gene expression,
and sensitivity to oxidative stress-induced cell death were
identical in cultured FECD and healthy endothelial cells.
Furthermore, restoration of a normal telomere length in
culture was not associated with the reactivation of telomerase
activity, suggesting that the normal phenotypes found in
cultured FECD cells would result from the selection of the
less affected FECD cells.
MATERIALS AND METHODS
Mitochondrial levels, mtDNA integrity, telomere shortening,
oxidant-antioxidant gene expression, and sensitivity to oxida-
tive stress-induced cell death were investigated in healthy and
FECD explants and cultured cells. All experiments performed
in this study were conducted in accordance with the
Declaration of Helsinki, and the research protocol received
approval by the Maisonneuve-Rosemont Hospital and the CHU
de Québec-Université Laval institutional ethics committees.
Corneal endothelium and Descemet’s membrane specimens
were collected from 21 consenting patients (60–83 years of
age; mean 6 SD 72 6 7 years of age) with late-stage FECD at
the time of their corneal transplantation.25 Twenty-four healthy
human corneas (50–82 years of age; mean 6 SD 65 6 9 years
of age) unsuitable for transplantation were obtained from our
local eye bank (Banque d’Yeux du Centre universitaire
d’ophtalmologie).
Cell Culture
Healthy Corneal Endothelial Cells. Healthy corneas
were obtained within 48 hours of death. Corneas were kept in
Optisol-GS corneal storage medium (Bausch & Lomb, Ro-
chester, NY, USA) at 48C until isolated from corneal endothelial
cells.26 Descemet’s membrane was peeled from the corneas
and incubated overnight in growth medium at 378C and 8%
CO2. Treatment with 0.02% ethylene-diamine-tetra-acetic acid
(Sigma Life Science, St. Louis, MO, USA) for 20 to 45 minutes
and gentle up and down agitation of the pipet were used to
detach the cells from the Descemet’s membrane. Loose cells
were then seeded in culture dishes covered with FNC coating
mix (Athena Enzyme Systems, Baltimore, MD, USA) in
OptiMem-I (Invitrogen, Burlington, ON, Canada) culture
medium supplemented with 8% fetal bovine serum (HyClone,
Logan, UT, USA), 5 ng/mL human epidermal growth factor
(Austral Biologicals, San Ramon, CA, USA), 20 ng/mL nerve
growth factor (Biomedical Technologies, Stoughton, MA, USA),
100 lg/mL bovine pituitary extract (Biomedical Technologies),
20 lg/mL ascorbic acid (Sigma), 0.08 % chondroitin sulfate
(Sigma), 25 lg/mL gentamicin sulfate (Schering, Pointe Claire,
QC, Canada), and 100 IU/mL penicillin G (Sigma).27 For gene
profiling analyses, cells were grown and cultured for 24 days
post confluence, with the addition of hydrocortisone (0.4 lg/
ml; Calbiochem, Etobicoke, ON, Canada) during the last 7 days
of culture. Hydrocortisone is used to improve the maturation
of corneal endothelial cells.
FECD Corneal Endothelial Cells. Endothelial cells from
the surgical specimens were isolated and cultured following
the same protocols as for healthy cells.
Corneal Stromal Fibroblasts and HT1080. Corneal
stromal fibroblasts from a 68-year-old donor and fibrosarcoma
cells (HT1080) were cultured to full confluence in Dulbecco’s
modified Eagle medium (Wisent, St-Bruno, Quebec, Canada)
with 10% fetal bovine serum (Wisent) and 1% penicillin/
streptomycin (Wisent) at 37 8C, 5% CO2. Healthy and FECD
corneal endothelial cells were cultured up to passage 3. Age,
sex and clinical diagnosis of all donors from whom corneal
tissue was used in this study are listed in Table 1.
DNA Isolation
For the mtDNACD4977 and mtDNA levels and telomere length
analyses, total DNA (mitochondrial and nuclear) from healthy
and FECD corneal endothelial cells was purified using DNeasy
blood and tissue kit (Qiagen, Toronto, ON, Canada) according
to the manufacturer’s protocol and with a RNase A treatment.
Analyses of mtDNACD4977 and mtDNA Levels by
PCR
Levels of mtDNACD4977 and total mtDNA were measured using
a Rotor-Gene Q real-time thermocycler (Qiagen). PCR ampli-
fications were performed with previously published primers
designed to amplify mtDNACD4977, total mtDNA, and genomic
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DNA 18S.14,28 Amplification was achieved using the primer
sets shown in Table 2.
The mtDNACD4977 primer set spans both sides of the
common deletion. These primers, under our PCR conditions
and a short primer extension time, allowed for DNA
amplification of the deleted mtDNA molecules only. These
primers are located in the cytochrome c oxidase II coding
region, just outside the deleted region. The amplification was
done with 10 ng of total DNA. Total mtDNA molecules were
amplified with primers located in a region of the mitochondrial
genome without reported deletion located in the 7S DNA
coding region. A standard curve (5, 1, 0.1, 0.01, and 0.001 ng
of total DNA/reaction) was performed using the total mtDNA
primers. For each sample, the amplification level of
mtDNACD4977 primers was compared with the standard curve,
and a ratio of mtDNA molecules containing the 4977-bp
deletion-to-total mtDNA molecules (mtDNACD4977:mtDNA)
ratio was derived. Samples with a cycle threshold (Ct) value
over 35 amplification cycles were considered negative for the
presence of mtDNACD4977. PCR reactions were performed in
20-lL reaction volumes containing 13 Brilliant III Ultra Fast
SYBR Green Master Mix (Agilent Technologies, Santa Clara, CA,
USA) and 500 nM of each primer. PCR conditions were 3
minutes at 958C, followed by 40 cycles of 20 seconds at 958C
and 20 seconds at 608C.
The mtDNA levels were measured with the previously
described primer set and a primer set for nuclear genome
located in the 18S ribosomal subunit DNA coding region, as
shown in Table 2.28 Amplification using the mtDNA primers
was done with 0.25 ng of total DNA. A standard curve (5, 1,
0.5, 0.05, and 0.005 ng of total DNA/reaction) was performed
with the 18S primers. For each sample, the amplification level
of mtDNA primers was compared with the 18S DNA coding
region standard curve, and a mtDNA molecules-to-18S coding
region ratio (mtDNA:18S DNA) was derived. PCR conditions
were the same as those described above for the mtDNACD4977
primer set.
Mitochondrial Staining
Corneal endothelial cells (healthy and FECD) were cultured 24
days post confluence prior to mitochondrial staining, whereas
central Descemet’s membrane and attached endothelium
explants were initially kept in Optisol-GS. Mitochondrial
staining was performed using the Mitotracker Red CMXRos
dye (Life Technologies, Burlington, ON, Canada) with minor
modifications to the manufacturer’s protocol. Briefly, samples
were washed twice with prewarmed (378C) OptiMem-I to
remove serum oxidases from the culture medium and
incubated in 250 nM (for cultured cells) or 40 nM (for
explants) Mitotracker dye diluted in OptiMem-I for 40 minutes
in the dark at 378C with 8% CO2. Samples were then washed
twice with warm OptiMem-I (378C), fixed in OptiMem-I
containing 3.7% formaldehyde (Laboratoire Mat, Montreal,
QC, Canada) in the dark at 378C with 8% CO2 for 15 minutes,
and washed again twice with OptiMem-I. Next, samples were
put on a microscope slide, mounted with SlowFade Gold
antifade (Life Technologies), observed, and imaged.
Relative Telomere Length Analysis
Relative telomere length was assayed using a Rotor-Gene Q
real-time thermocycler (Qiagen) with previously described
primers.29–31 Amplification was achieved using the primer sets
and standards listed in Table 2. The telomere primer set allows
amplification of telomeres of variable fragments over a size
range because they can anneal at various distances apart on the
telomeric repeats. The amplification was done with 0.5 ng of
total DNA. A telomere standard oligomer of 14 repeats of the
sequence 50TTAGGG was used for the standard curve. A
standard curve (60, 6, 0.6, 0.06, 0.006, and 0.0006 pg of total
telomere standard/reaction) was performed with this oligomer
with the addition of 2 pg of plasmid DNA without telomeric
repeat (PCruzGFPL; Santa Cruz Biotechnology, Dallas, TX, USA)
per reaction to allow efficient PCR reaction. For each sample,
the amplification level of telomere primers was compared with
the telomere standard curve, and a telomere repeat (T)-to-
telomere standard (S) (T:S) ratio was derived.
The HBG primer set allows amplification of the hemoglobin
gene, which is present in two copies in the human genome.
Amplification using these primers was done with 0.5 ng of total
DNA. An HBG standard oligomer corresponding to the coding
DNA sequence of the gene was used for the standard curve. A
TABLE 1. Classification of Age and Sex of Healthy and FECD Donors
Used in This Study by Figure
Healthy (H)
or FECD (F) Age Sex Figure
F 60 Male 1A,1C,2A,2B
F 66 Female 1A,1B,1C,2A,2B
F 82 Female 1A,1B,1C,2A,2B
F 67 Male 1A
F 78 Male 1A
H 66 Female 1A,2A,2B
H 58 Male 1A,1C,2B
H 82 Female 1A,1C,2A,2B
H 72 Male 1A,1C,2A
H 77 Male 1A
H 66 Male 1A
F 83 Female 1A,2A
F 72 Male 2A
F 67 Male 1A,2A
F 66 Male 1A,2A
F 64 Male 1A
F 82 Male 1A
H 54 Male 1A,2A
H 69 Male 1A,2A
H 50 Female 1A
H 63 Male 1A,2A
H 77 Male 1A,2A
H 73 Male 1A,2A
H 50 Female 1A
H 82 Female 1B
H 66 Female 1B,1C
H 61 Female 1B
H 61 Female 1B
F 76 Male 1B
F 69 Male 1B
F 67 Male 2A
F 78 Male 2A
H 72 Female 2C
H 70 Female 2C
H 64 Female 2C
F 70 Male 2C
F 69 Male 2C
F 69 Male 2C
H 50 Female 3A,3B
H 59 Female 3A,3B
H 62 Female 3A,3b
H 72 Female 3A,3B
F 76 Male 3A,3B
F 79 Male 3A,3B
F 81 Male 3A,3B
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standard curve (20, 2, 0.2, 0.02, 0.002, and 0.0002 pg of total
HBG standard/reaction) was performed with this oligomer. For
each sample, the amplification level of the HBG primers was
compared with the HBG standard curve, and an ‘‘S’’ ratio of
HBG copies-to-HBG standard (HBG copy: HBG standard) ratio
was derived. A final ratio of T:S was derived to compare relative
telomere length per cells. In all cases, PCR reactions were
performed in 20 lL of reaction volumes containing 13 Brilliant
III Ultra Fast SYBR Green Master Mix (Agilent Technologies)
and 500 nM of each primer. PCR conditions were 3 minutes at
958C, followed by 40 cycles of 20 seconds at 958C and 60
seconds at 568C.
Telomerase Repeat Amplification Protocol Assay
Corneal endothelial cells from healthy and FECD donors, a
HT1080 fibrosarcoma telomerase-positive cell line and a 68-
year-old telomerase-negative corneal keratocyte cell strain
were cultured to full confluence. Total protein extracts were
prepared, and telomerase catalytic activity was determined by
using a telomerase repeat amplification protocol (TRAP) assay
(TRAPeze telomerase detection kit; Chemicon International,
Temecula, CA, USA) according to the manufacturer’s protocol.
The TRAP assay was performed using 0.6 lg of protein extract
(equivalent to 1500 cells). The reaction mixture was incubated
at 948C for 30 seconds, 598C for 30 seconds, and 728C for 1
minute for 30 cycles on a thermocycler. The amplified
products were resolved on a 12.5% polyacrylamide non-
denaturing gel. The gel was then stained for 30 minutes with
Redsafe nucleic acid staining solution (iNtRON; Biotechnology,
Inc., Toronto, ON, Canada).
UVA and H2O2 Exposure and Cell Viability Analysis
Corneal endothelial cells were cultured in 96-well plates until
full confluence. For UVA irradiation, cells were washed twice
with PBS (Wisent) and covered with phosphate-buffered saline
for irradiation with a UVA lamp emitting UVA1 wavelengths
(340–400 nm) with <0.01% of UVA2 wavelengths (315–340
nm; UVP 365 nm lamp with filter; UVP, Upland, CA, USA). Cells
were irradiated with 0, 100, 200, 300, 400, 500, or 600 kJ/m2
of UVA and then incubated for 24 hours.
For H2O2 experiments, cells were incubated for 24 hours in
the presence of H2O2 at concentrations of 0, 200, 400, 600,
800, and 1000 lM in culture medium at 378C and 8% CO2. Cell
viability was then assessed using the Live/Dead viability/
cytotoxicity kit for mammalian cells (Life Technologies)
according to the manufacturer’s protocol. Briefly, cells were
washed twice with phosphate-buffered saline and incubated in
phosphate-buffered saline with 4 mM calcein AM and 2 mM
ethidium homodimer-1 for 35 minutes in the dark at room
temperature. They were washed again with phosphate-
buffered saline and observed. Signal quantification was done
with the AxioVision version 4.8.2 software (Zeiss, Germany).
For normalization, the average number of viable cells per field
in the control sample (i.e., 0 kJ/m2 or 0 lM H2O2) was set as
the baseline for 100% viability. Subsequent conditions were
reported as the ratio of number of viable cells per field-to-
number of viable cells per field in the control. At least 8 fields
were analyzed for each H2O2 concentration and UVA dose.
Gene Profiling Analysis
Gene profiling was performed as previously described.32 Cells
from healthy donors and FECD patients were cultured for 24
days post confluence, with the addition of hydrocortisone (0.4
lg/ml; Calbiochem) during the last 7 days. RNA was isolated
from the samples using TRizol reagent according to the
manufacturer’s protocol (Ambion; Life Technologies). Cyanine
3-CTP (Agilent protocol)-labeled cRNA targets were prepared
from 200 ng of total RNA from the different samples using the
One-Color microarray-based gene expression analysis kit
(Agilent Technologies). cRNA (600 ng) was then incubated
on a G4851A SurePrint G3 human Ge 83 60 K array slide
(60,000 probes; Agilent Technologies). Slides were hybridized
for 18 hours, washed, and scanned using a SureScan scanner
(Agilent), and heat maps were analyzed for selected genes
using Arraystar version 4.1 software (DNAstar, Madison, WI,
USA).
Statistical Analysis
KaleidaGraph version 4.1.3 software (Synergy Software,
Reading, PA, USA) was used to generate statistical analysis.
Wilcoxon test was used to compare the mtDNA, mtDNACD4977,
and T:S Q-PCR ratio levels of the different samples. Wilcoxon is
a nonparametric statistical hypothesis test for paired samples
or repeated measurements from a single sample. Box plots and
median values illustrate data.13 Statistical analyses for the
microarray experiment were performed using the robust
TABLE 2. Q-PCR Oligonucleotide Primers and Standards Used in This Study
Parameter Primer Amplicon Size, bp Reference
18S ribosomal RNA
coding region
F 50-TAGAGGGACAAGTGGCGTTC 104 28
R 50 -CGCTGAGCCAGTCAGTGT
mtDNA F 50-AATCAATTGGCGACCAATGG 101 14
R 50 -CGCCTGGTTCTAGGAATAATGG
mtDNACD4977 F 50-TATTAAACACAAACTACCACCTACC 132 14
R 50 -GGCTCAGGCGTTTGTGTATGAT
HBG F 50-GCTTCTGACACAACTGTGTTCACTAGC 120 29
R 50 -CACCAACTTCATCCACGTTCACC
Telomere F 50-GGTTTTTGAGGGTGAGGGTGAGGGTGAG variable 31
R 50 -TCCCGACTATCCCTATCCCTACCCCTATC
Standard Oligomer





120 NCBI GenBank identifier KP309825.1
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multiarray analysis for background correction of the raw data
values. Microarray data shown in this study comply with the
Minimum Information About a Microarray Experiment (MI-
AME) requirements.33
RESULTS
Differences Between Levels of mtDNA in Healthy
and FECD Explants and Cultured Corneal
Endothelial Cells and Those of mtDNACD4977
Figure 1A illustrates the amount of mtDNA per corneal
endothelial cell as expressed by the ratio total mtDNA
molecules-to-total ribosomal 18S subunit DNA sequences
(mtDNA:18S). The amount of mtDNA per cell was found to
be 11 times higher in FECD explants (median: 11.63) than in
healthy explants (median: 1.06). It was also significantly higher
in FECD explants (median: 11.63) than in FECD cultured cells
(median: 2.57) No significant differences were found between
healthy explants, healthy cultured cells (median: 1.23) and
FECD cultured cells.
These findings were qualitatively confirmed by mitochon-
drial staining using Mitotracker dye. The mitochondrial signal
was stronger in FECD explants than in healthy explants, healthy
cultured cells, and FECD cultured cells. The mitochondrial
signal was also unevenly distributed in FECD explants, some
cells (»20%–30%) clearly showed a stronger signal, whereas a
uniform distribution was observed in healthy explants, healthy
cultured cells, and FECD cultured cells (Fig. 1B).
Figure 1C illustrates the level of mtDNA detected per
mitochondrial genome expressed in terms of ‘‘mtDNA mole-
cules containing the common deletion/total mtDNA molecules
(mtDNACD4977:total mtDNA). No significant accumulation of
mtDNACD4977 was seen in FECD cultured cells, as documented
by the similar mtDNACD4977:total mtDNA ratios found in
healthy (0.07%) and FECD (0.13%) cells in culture (Fig. 1C).
Telomeres Are Shorter in FECD Patients, but
Cultured Corneal Endothelial Cells From Healthy
and FECD Subjects Showed an Increased Telomere
Length Without Telomerase Gene Expression and
Activity
Telomeres in cultured cells (relative telomere length T:S for
healthy: 12.6, and FECD: 13.7) were significantly longer than in
those in the explants (T:S healthy: 4.4 and FECD: 0.9) (Fig. 2A).
Notably, telomeres in FECD explants were significantly shorter
than telomeres from healthy explants, a difference that was not
observed in culture.
As the increase in telomere length observed in cultured
cells could be explained either by an increase in telomerase
activity or by the selection in culture of cells with longer
telomeres, the two options were evaluated. To assess
telomerase activity, we first analyzed gene expression of the
FIGURE 1. Mitochondrial level and integrity in healthy and FECD corneal endothelium explants and cultured cells. (A) The amount of mtDNA per
cell was measured using a ratio of the mtDNA level to a known number of copies per cell gene (i.e., gene coding for 18S ribosomal subunit). The
mtDNA-to-18S ratio was significantly higher in FECD explants (median: 11.63) than in healthy explants (median: 1.06), healthy cultured cells
(median: 1.23), and FECD cultured cells (median: 2.57; *P < 0.01). (n¼23 subjects; n¼5 experimental repeats per subject; median 67 years of age).
(B) Mitochondrial density was assessed using Mitotracker Red CMXRos. Corneal endothelial cell mitochondria were found in greater numbers in
FECD explants than in healthy explants, healthy cultured cells, and FECD cultured cells. The mitochondrial signal in FECD explants was unevenly
distributed; some cells (»20%–30%) showed a much stronger signal than others. Mitochondrial signal distribution was otherwise uniform and
similar among other groups. (n ¼ 8 samples; median age: 67.5 years). White scale bar: 50 lm. (C) Quantification of mtDNACD4977 in FECD and
healthy cultured corneal endothelial cells. mtDNACD4977 and total mtDNA were detected by Q-PCR. Total DNA, including mtDNA, was extracted
from confluent cultures at passage 3. Specific primer sets were used for mtDNACD4977 and mtDNA detection, and the mtDNACD4977-to-total mtDNA
ratio was derived. No significant differences in mtDNACD4977-to-total mtDNA ratio were found between the two conditions; median values of 0.07%
and 0.13% for healthy and FECD, respectively. (n¼ 8 subjects; n¼ 4 experimental repeats per subject; median age: 66 years).
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telomerase-coding gene (TERT) in healthy and FECD cultured
cells and found that it was absent in both cases (Fig. 2B).
Telomerase activity was then verified using the TRAP assay,
which clearly confirmed the absence of telomerase activity in
healthy and FECD cultured cells (Fig. 2C). Cells from HT1080, a
fibrosarcoma cell line known to express telomerase, were used
as positive controls, and normal human corneal stromal diploid
keratocytes, known not to express telomerase, were used as
negative controls.34
Cultured Corneal Endothelial Cell From Healthy
and FECD Subjects Are Equally Sensitive to UVA-
and H2O2-Induced Cell Death
Sensitivities to UVA- and H2O2-induced cell death were similar
in FECD and healthy cultured endothelial cells, with one
exception. FECD cells were more resistant to H2O2-induced
cell death than healthy cells at a concentration of 1000 lM (P
< 0.05) (Fig. 3A).
Expression of Genes Implicated in Oxidative Stress
Response Is Similar to That in Cultured Corneal
Endothelial Cells From Healthy and FECD Subjects
It has been previously shown that genes implicated in
antioxidant protection, ROS metabolism, apoptosis, and
signaling in response to oxidative stress are deregulated in
corneal endothelial cells of FECD patients’ explants (Table 3).
Gene expression analysis in cultured endothelial cells from
healthy and FECD subjects showed no deregulation in the
expression of genes implicated in antioxidant protection, ROS
metabolism, apoptosis, and signaling in response to oxidative
stress (Table 3). The only exception was the transcript level of
peroxiredoxin 6 that was found to be significantly up-regulated
in cultured FECD cells compared to healthy cells.
DISCUSSION
Increased mtDNA and mtDNACD4977 Levels in
Healthy and FECD Corneal Endothelium Explants
and Cultured Cells
Increases in cell mitochondria content have been associated
with multiple diseases, including breast cancer, hepatitis C
virus infection, and chronic obstructive pulmonary dis-
ease.35–38 The increase was described as a compensatory
mechanism against defects in mitochondria harboring mutated
mtDNA and/or a defective respiratory system and an early
cellular response to oxidative stress.36,39 An abnormal accu-
mulation of mitochondria was documented in a mouse model
FIGURE 2. Telomeres are shorter in FECD patients, but cultured
corneal endothelial cells from healthy and FECD subjects show an
increased telomere length without telomerase gene expression and
activity. (A) Relative telomere length was evaluated by Q-PCR in
corneal endothelium explants and cultured cells from healthy and
FECD subjects. Total DNA, including mtDNA, was extracted from
explants and from confluent cultured cells at passage 3. The ratio of
telomeric Q-PCR amplification signal (T)-to-the signal generated by the
single-copy gene HBG (S) was determined (T:S). Relative telomere
length was greater in cultured cells (healthy: T:S¼ 12.6, and FECD: T:S
¼ 13.7) than in explants (Healthy: T:S¼ 4.4, and FECD: T:S¼ 0.9). The
relative telomere length was significantly less for FECD explants than
for healthy explants. (*P < 0.04; n¼17 subjects; median age: 69 years).
(B) Gene expression of telomerase-coding gene (TERT) in postcon-
fluent corneal endothelial cultured cells from healthy and FECD
subjects using gene expression microarray technique. The scale used to
display the log2 expression level values was determined by the
hierarchical clustering algorithm of the Euclidian metric distance
between genes. White indicates a very low and black a very high gene
expression level. The three genes shown in the lower lines (GOLGA1,
TUBB, and B2M) are housekeeping genes used as experimental
controls, with stable transcription level, independent of cell type and
conditions. Results indicate a similar absence of TERT gene expression
in healthy and FECD cultured cells. (n ¼ 6 subjects; 3 healthy (60, 66
and 82 years old) and 3 FECD subjects (58, 66 and 82 years old);
median age: 66 years). (C) Telomerase activity measured in cultured
corneal endothelial cell from healthy and FECD subjects using the
TRAP assay. (n¼6; 3 healthy; age, 64, 70, and 72 years old) and 3 FECD
(69, 69, and 70 years old; subjects median age: 69.5 years). HT1080 is a
telomerase-positive fibrosarcoma cell line, and HT1080 HI is the heat-
inactivated control. F68 is a 68-year-old telomerase-negative corneal
stromal keratocyte strain, and C is a negative control without protein
extract. The 36-bp fragment is an internal PCR amplification control
band. No telomerase activity was found in either type of cultured cells,
healthy or FECD.
FIGURE 3. Similar sensitivity to UVA- and H2O2-induced mortality in
cultured FECD and healthy corneal endothelial cells. (A) Cells were
irradiated with UVA doses ranging from 0 to 600 kJ/m2. Cell viability
was measured 24 hours after irradiation. The results show no
significant differences in UVA-induced cell death sensitivity between
cultured corneal endothelial cells from healthy and FECD subjects.
Data are means 6 SD. (n¼7; n ‡ 3 subjects per condition; median age:
72 years). (B) Cells were exposed to H2O2 doses ranging from 0 to
1000 lM. Cell viability was measured 24 hours later. No significant
differences in H2O2-induced cell death were observed between healthy
and FECD cells from 0 to 800 lM. In fact, FECD cells seemed to be less
susceptible to H2O2-induced cell death, and FECD cells exposed to
1000 lM were significantly more resistant to H2O2-induced cell death
than healthy cells (*P < 0.05). Data are means 6 SD (n¼7; median age:
72 years).
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of FECD (Col8a2 knock-in).40 In the present study, we
documented increased levels of mitochondria and mtDNA
content in FECD explants (Fig. 1), two parameters that usually
correlate. Corneal endothelial cell counts, on the other hand,
are known to progressively decline in FECD. We thus
hypothesize that the surviving endothelial cells may have to
increase their mitochondrial content to produce the ATP
needed by the Na/K ATPase ion pump in order to maintain
corneal stromal deturgescence. This, in turns, leads to an
increase in ROS production by the mitochondrial respiratory
chain, and ROS are known to catalyze the apparition of mtDNA
deletion, such as the mtDNACD4977.41,42 In accordance with
this hypothesis, Czarny et al.43 recently documented an
increase in the number of mtDNA copies and mtDNACD4977
in the corneal endothelium of FECD patients compared with
healthy subjects. Because mtDNA accumulates with age,36,39
FECD and healthy groups were matched for age in this study.
We then showed that culturing FECD cells restores a normal
phenotype in terms of mitochondria and mtDNA content (Fig.
1). Using Mitotracker dye, we found that the mitochondrial
signal was uneven in FECD explants, with 20% to 30% of the
cells showing a much stronger signal (Fig. 1B). This may
indicate that these high mitochondria-containing cells were
highly active and produced more ROS, which in turn would
further exacerbate the oxidative damage and lead to an
increase in mtDNA deletions.3,9,10,23,43 Increased levels of
mitochondrial ROS have indeed been documented in FECD
cells.12 Beyond a certain threshold, increased ROS levels
induce release of mitochondrial cytochrome c, leading to
apoptosis.39 This may explain in part endothelial cell attrition
in FECD.
Czarny et al.43 also documented an increase in occurrence
of mtDNACD4977 in FECD corneal endothelium explants
compared with that in healthy explants. We found no
significant differences in mtDNACD4977 levels between healthy
(0.07%) and FECD (0.13%) and healthy cultured endothelial
cells (Fig. 1). Notably, a similar percentage has been reported
for normal endothelial explants (0.13%),14 supporting hypoth-
eses of either a rehabilitation by culture or the selection of cells
containing less deletion.
Relative Telomere Length, Telomerase Gene
Expression, and Telomerase Activity in Isolated
Corneal Endothelial Cells From FECD
Telomeres were 4 times shorter in FECD explants than in
healthy explants (Fig. 2A). DNA telomeric repeats stabilize
chromosomes and help preserve genome integrity. Telomeric
DNA, however, is highly sensitive to oxidative damage, which
causes telomeric shortening and accelerates cellular senes-
cence and cell death.15,44 Because of the significant role of
oxidative stress in FECD, we investigated telomere lengths in
corneal endothelial cells from FECD and from healthy subjects.
Once telomere erosion reaches a certain threshold, the cell
enters a senescent state or exhibits chromosomic aberra-
tions.45
Our results also showed that telomeres in cultured cells
(healthy and FECD) were significantly longer than telomeres
TABLE 3. Comparative List of Genes More Than Two-Fold Down- or Up-Regulated in FECD Explants and Cultured Cells Relative to Normal, as
Detected by PCR Array and Gene Profiling
Gene Description Symbol
Explants* Cultured Cells†
Fold Regulation Fold Regulation
Antioxidant
Metallothionein 3 MT3 5.65 1.346
Superoxide dismutase 3. extracellular SOD3 5.37 1.802
Peroxiredoxin 1 PRDX1 2.02 1.026
Peroxiredoxin 2 PRDX2 4.3 1.236
Peroxiredoxin 5 PRDX5 3.05 1.311
Peroxiredoxin 6 PRDX6 3.29 2.663
Superoxide dismutase 2. mitochondrial SOD2 2.65 1.147
Cytoglobin CYGB 2.23 1.558
Thioredoxin reductase 1 TXNRD1 2.23 1.06
Albumin ALB 3.34 1.135
ROS metabolism
Neutrophil cytosolic factor 2 NCF2 3.48 1.209
Nitric oxide synthase 2A (inductible. hepatocytes) NOS2A 3.91 1.131
Arachidonate 12-lipoxygenase ALOX12 2.31 1.059
Apoptosis
BCL2/adenovirus E1B 19 kD-interacting protein 3 BNIP3 4.61 1.027
Glyceraldehyde-3-phosphate dehydrogenase GAPDH 2.61 1.088
Signaling in response to oxidative stress
Dual specificity phosphatase 1 DUSP1 3.12 1.057
Oxidative-stress response 1 OXSR1 2.18 1.708
Serine/threonine kinase 25 (STE20 homolog. yeast) STK25 2.16 1.119
Other oxidative stress responsive genes
Angiopoietin-like 7 ANGPTL7 4.74 1.824
Selenoprotein P. plasma. 1 SEPP1 2.03 1.072
* Derived by PCR array analysis. Explants data reprinted with permission from Jurkunas UV, Bitar MS, Funaki T, Azizi B. Evidence of oxidative
stress in the pathogenesis of Fuchs’ endothelial corneal dystrophy. Am J Pathol. 2010;177:2278–2289.
† Derived by gene profiling analysis.
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from explants (healthy and FECD). The fact that no telomerase
(hTERT) gene expression and no telomerase activity could not
be detected in either healthy or FECD cultured cells (Fig. 2)
strongly favors the hypothesis of a selection in culture of cells
with longer telomeres, whether these are healthy or FECD
cells.
No Difference in UVA- and H2O2-Induced Cell
Death Sensitivity and in Gene Implicated in
Oxidative Stress Response Between Cultured
Endothelial Cells From Healthy and FECD Subjects
FECD cells are poorly protected against oxidative stress, and
they are exposed to both endogenous (mitochondrial respira-
tory chain) and exogenous oxidation (UVA) throughout life,
which makes them prone to cell death.9,10,46,47 UVA wave-
lengths were used in this experiment because they represent
75% of the terrestrial UV radiations, they are known to reach
the corneal endothelium, and they efficiently induce ROS.6–8,48
H2O2, an oxidizing component induced by the mitochondrial
respiratory chain, was also used to assess sensitivity to
oxidative stress. Both UVA- and H2O2-induced cell death
methods showed that FECD and healthy cultured cells behave
similarly in the presence of oxidative stress (Fig. 3). FECD cells
seemed slightly less sensitive than healthy cells, but this was
only statistically significant for the highest concentration (1000
lM).
The similarity between FECD and healthy cultured cells was
further confirmed by gene profiling results showing that major
genes implicated in antioxidant protection, ROS metabolism,
apoptosis, and signaling in response to oxidative stress were
not deregulated (i.e., were less than 2-fold down- or up-
regulated) in FECD cultured cells, with the only exception
being peroxiredoxin 6 upregulation (Table 3). Peroxiredoxin 6
is a cytoprotective antioxidant enzyme working against
endogenous or exogenous peroxide, widely expressed in
tissues.49 Although interesting, investigation of its role in
FECD was beyond the purpose of this study. As shown in Table
3, we did not find a gene deregulation similar to that reported
in explants of FECD corneal endothelium in cultured cells.10
Overall, these results converge to highlight the fact that
endothelial cell culture allows rehabilitation of the oxidant-
antioxidant balance in FECD.
In this study, we showed that late stage FECD corneal
endothelium contains cells that are comparable to healthy
endothelial cells in terms of mitochondrial amount and
integrity, telomere length, sensitivity to oxidation, and
oxidant-antioxidant gene expression. We also showed that
these functional cells could be selected and amplified by cell
culture. This could explain previous results showing that an
endothelium tissue-engineered using cultured corneal endo-
thelial cells from patients with end-stage FECD cells retains
some functionality.24 Currently, the only treatment for FECD is
transplantation of an allogeneic corneal endothelium, using
donor tissue. This work opens the door to a new therapeutic
concept, where rehabilitation of a diseased FECD endothelium
could potentially be achieved through reimplantation of a new
corneal endothelium tissue engineered from cultured autolo-
gous endothelial cells.
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d’Ophtalmologie de Québec for providing the donor corneas and
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